Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553110 · ClinicalTrials.gov registry record
An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 41
- Enrollment target
NCT01553110: Completed study, sponsored by Virginia Commonwealth University.
NCT01553110 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01553110 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
This is a study to learn more about the common cold from studying the nasal secretions produced during a cold or episode of allergic rhinitis.
Primary Outcome
To measure the biophysical properties of nasal secretions for improved mucus clearance.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-03 |
| Est. Completion | 2019-04 |
What the finished NCT01553110 record still lists
NCT01553110 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01553110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01553110 about?
NCT01553110 is a clinical study titled "An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms". This is a study to learn more about the common cold from studying the nasal secretions produced during a cold or episode of allergic rhinitis.
What is the current status of trial NCT01553110?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2012-03. Estimated completion is 2019-04.
Who is sponsoring clinical trial NCT01553110?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia